Accreditation/Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Celgene International II Sàrl.

Cancer Summaries and Commentaries™ Update from Stockholm: European Perspectives on the Future Application of CAR T-Cell Therapies


Release Date: February 28, 2019
Expiration Date: February 28, 2020
Media: Internet - based

Activity Overview

This online Physicians’ Education Resource,® LLC activity, Cancer Summaries and Commentaries™: Update from Stockholm: European Perspectives on the Future Application of CAR T-Cell Therapies, is designed to update physicians on data presented at the 23rd Annual Congress of the European Hematology Association, which took place June 14-17, 2018, in Stockholm, Sweden. During this online activity, the program faculty, Andre Goy, MD, MS, will review reported data from 4 clinically relevant abstracts. For each abstract, a short summary of key clinical data is accompanied by expert perspectives that provide insight into how clinicians can apply these findings to their clinical practice to improve patient care.

Benefits of Participating

  • Hear expert perspective on the clinical context of data on current and emerging CAR T-cell therapies for the treatment of non-Hodgkin lymphoma (NHL)
  • Stay up-to-date on reported long-term follow-up data and new analyses of clinical trial data for the use of CAR T-cell therapies for patients with NHL
  • Benefit from expert discussion on the management and mitigation of adverse events associated with the use of CAR T-cell therapies in NHL

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Celgene International II Sàrl.

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review audio files/content until you finish the presentation.
  • At the end of the activity, educational content/audio files will be available for your reference.
  • In order to receive a CME/Ce certificate, you must complete the activity.
  • Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” You may immediately download a CME/CE certificate upon completion of these steps.


Target Audience

This educational activity is directed toward hematologist/oncologists, medical oncologists, and fellows who treat patients with hematologic malignancies.

Surgical oncologists, radiation oncologists, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of hematologic malignancies are also invited to participate.

Learning Objectives

After successful completion of this activity, you should be better prepared to:

  • Describe current and emerging roles for CAR T cells in the management of NHL in the context of their mechanism of action, manufacturing, and delivery
  • Explain recent emerging evidence concerning the use of CAR T cells in the management of follicular lymphoma (and rare subsets of NHL)
  • Place recent evidence in the context of evolving clinical perspectives on the use of CAR T cells, including the management of treatment-related toxicities in patients receiving these strategies

Faculty, Staff, and Planners' Disclosures

Faculty

Andre Goy
Andre Goy, MD, MS
Chairman and Executive Director
Lymphoma Division Chief
John Theurer Cancer Center
Hackensack, NJ
Chief Science Officer – RCCA
Lydia Pfund Chair for Lymphoma
Professor of Medicine, Georgetown University
Washington, DC

Disclosures: Grant/Research Support: Johnson & Johnson, Celgene, Gilead/Kite (clinical trial support through institution); Consultant: Celgene; Speakers Bureau: Takeda, Johnson & Johnson/Pharmacyclics, Gilead/Kite; Advisory Board: Celgene, Takeda, Pharmacyclics, Johnson & Johnson, Acerta, Gilead/ Kite

The staff of PER® have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME/Ce activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any of the companies that provided commercial support for this activity.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
 123456
78910111213
14151617181920
21222324252627
28293031
Filter By